Nxera Pharma Co., Ltd. ( SOLTF) - Key Metrics
SOLTF Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2025Q4 | $85.99 | -$85.48 | -$1.38 | -$3.01 |
| 2025Q3 | $74.63 | -$18.48 | -$32.89 | -$34.01 |
| 2025Q2 | $93.78 | -$26.38 | -$2 | -$3 |
| 2025Q1 | $73.90 | -$8.45 | $6.82 | $5.61 |
| 2024Q4 | $76.25 | -$14.86 | -$122.08 | -$123.78 |
SOLTF Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2025Q4 | ? | -2.42 |
| 2025Q3 | ? | -13.40 |
| 2025Q2 | ? | -8.56 |
| 2025Q1 | ? | -26.70 |
| 2024Q4 | ? | -17.64 |
SOLTF Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2025Q4 | -0.36% | ? |
| 2025Q3 | -3.44% | ? |
| 2025Q2 | -0.33% | ? |
| 2025Q1 | 0.62% | ? |
| 2024Q4 | -11.81% | ? |
SOLTF
Price: $6.18
52 week price:
Payout Ratio Range:
Earnings Per Share: -0.89 USD
P/E Ratio: -6.11
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 642.1 million